Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label, Multicenter Study Evaluating Princess® RICH in Correction of Fine Lines

NCT03923634 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.

NCT NCT03923634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label, Multicenter Study Evaluating Princess® RICH in Correction of Fine Lines
Lead sponsor
Croma-Pharma GmbH
Phase
Not applicable
Overall status
Completed
Start date
October 16, 2018
Completion date
October 22, 2019
Enrollment
102 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lateral canthal lines, perioral rhytids